FDA Approved Indications The FDA-approved indications for Semaglutide are outlined as follows: Semaglutide was initially approved for use in the treatment of type 2 diabetes
For these reasons, a growing number of clinicians view GLP-1 medications as an essential ingredient in a well-rounded metabolic health optimization program, regardless of whether or not the patients in the program technically meet criteria for diabetes or obesity the conditions for which the FDA originally approved them
CoQ10 is prescribed orally or parenterally and used in the treatment of many diseases, including fibromyalgia, cardiovascular disease, and some neurological disorders such as Parkinsons disease, and Alzheimers disease (153, 154)
It goes away pretty quickly once your body gets adjusted to the peptide
But like any drug, its not without risks
It stores and concentrates the bile produced by the liver